Gene · 3860
KRT13: keratin 13
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. KRT13: keratin 13. Genes, record 3860. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/3860
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P13646 | Keratin, type I cytoskeletal 13 | 458 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents7
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 50654 | P13646 | Espacenet |
| WO 2025215055 A1 | 2025-10-16 | 104 | P13646 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 42934 | P13646 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 145905 | P13646 | Espacenet |
| JP 2019054813 A | 2019-04-11 | 231089 | P13646 | Espacenet |
| JP 2017121241 A | 2017-07-13 | 231089 | P13646 | Espacenet |
| JP 2015516143 A | 2015-06-08 | 231089 | P13646 | Espacenet |
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,594
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | KRT13 papers | Newest fiscal year |
|---|---|---|---|
| R01AI109023 | Defining P. falciparum resistance to artemisinin-based combination therapies | 35 | 2025 |
| R01AI124678 | Elucidating the molecular basis of piperaquine resistance in Plasmodium falciparum | 16 | 2025 |
| R37AI050234 | Defining the Role of PfCRT and PfMDR1 as Pleiotropic Mediators of Plasmodium falciparum Multidrug Resistance | 15 | 2025 |
| R01AI117017 | Chemogenomic Profiling of Plasmodium Falciparum Responses and Resistance | 12 | 2025 |
| P30DK050306 | Center for Molecular Studies in Digestive and Liver Diseases | 11 | 2025 |
| P30DK078392 | Digestive Health Center (DHC): Bench to Bedside Research in Pediatric Digestive Disease | 8 | 2025 |
| R01DC004336 | Engineering the Vocal Fold Mucosa | 8 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 7 | 2025 |
| R01EY021797 | Development of Stem Cell-based Therapies for Limbal Stem Cell Deficiency | 7 | 2025 |
| K24AI134990 | Mentoring in Translational Malaria Genomics | 6 | 2025 |
1 to 10 of 1,594Source NIH's project files
See all 1,594 nih grantsPapers2,936
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| KRT13 Drives Pancreatic Cancer Malignancy Via the PI3K/AKT-PPARG Axis While Enhancing Sensitivity to Navitoclax. | Med Sci Monit | 2026 | 42811535 | PubTator, text mining | PubMed |
| SHC1 affects oestrogen-driven differentiation and barrier function of vaginal epithelial cells via EGFR/Ras/ERK pathway. | J Obstet Gynaecol | 2026 | 42779257 | PubTator, text mining | PubMed |
| Genetic Relatedness of Cambodian Plasmodium falciparum Isolates Was Associated with Geography and Occupation. | Am J Trop Med Hyg | 2026 | 42772274 | PubTator, text mining | PubMed |
| A Barrier Betrayed: Hillock in Lung Squamous Cell Carcinoma. | Cancer Res | 2026 | 42740576 | PubTator, text mining | PubMed |
| Fabrication and Characterization of Melt-Electrowritten Hierarchical PCL Scaffolds for Conjunctival Tissue Engineering. | ACS Biomater Sci Eng | 2026 | 42679313 | PubTator, text mining | PubMed |
| Enzymatically Hydrolyzed Eggshell Membrane Promotes Keratinocyte Differentiation Associated With PKC and Akt Signaling Pathways. | J Food Sci | 2026 | 42644214 | PubTator, text mining | PubMed |
| F7 Drives Gastric Cancer Metastasis Through Anoikis Resistance and Tumor Microenvironment Remodeling. | Adv Sci (Weinh) | 2026 | 42606136 | PubTator, text mining | PubMed |
| Cytokeratin 13 and 17 expressions in oral epithelial dysplasia: correlation with the 5th WHO architectural and cytological features. | Odontology | 2026 | 42518059 | PubTator, text mining | PubMed |
| Integrated ATAC-Seq and RNA-Seq Identify ATF3 as a Tumor Suppressor in UVB-Induced Keratinocyte Carcinogenesis. | Biology (Basel) | 2026 | 42510649 | PubTator, text mining | PubMed |
| Keratins and desmosomal proteins: Utility for molecular subtype identification in muscle-invasive bladder cancer. | Virchows Arch | 2026 | 42406031 | PubTator, text mining | PubMed |
1 to 10 of 2,936
See all 2,936 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/3860
GET https://conductscience.org/api/genes/v1/3860/grants?page=2